Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).

The Journal of rheumatology - 1 May 2000

Falkner D, Wilson J, Fertig N, Clawson K, Medsger T A, Morel P A

Abstract excerpt

OBJECTIVE: To determine the clinical and immunogenetic features of systemic sclerosis (SSc) patients with anti-RNA polymerase (RNAP) or anti-fibrillarin antibodies. METHODS: DNA typing for HLA-DR and DQ alleles was performed in 292 patients with SSc, including 81 with anti-RNAP and 24 with anti-fibrillarin antibodies. The remaining patients had anti-topoisomerase I (anti-topo I; 71), anti-centromere (ACA; 56),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Antibodies, Antinuclear

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Autoantibodies

Share to DNA-Directed RNA Polymerases

Share to Gene Frequency

Share to HLA-DQ Antigens

Share to HLA-DR Antigens

Share to Scleroderma, Systemic

Source

Identifiers

PMID: 10813287

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).PMID 10813287Read ↗

Anti-RNA polymerases and other autoantibody specificities in systemic sclerosisSemantic proximity Read ↗

Disease-related autoantibody profile in patients with systemic sclerosisSemantic proximity Read ↗

Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associationsSemantic proximity Read ↗

Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis.Semantic proximity Read ↗

HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities.Semantic proximity Read ↗

Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis.Semantic proximity Read ↗

HLA and autoimmunity in scleroderma (systemic sclerosis).Semantic proximity Read ↗

Autoantibody to th ribonucleoprotein (nucleolar 7–2 rna protein particle) in patients with systemic sclerosisSemantic proximity Read ↗

Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP.Semantic proximity Read ↗

Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodiesSemantic proximity Read ↗

Autoantibody to U3 Nucleolar Ribonucleoprotein (Fibrillarin) In Patients with Systemic SclerosisSemantic proximity Read ↗

HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.